Panagiotis Baliakas

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Bhoi, Sujata; Ljungström, Viktor; Baliakas, Panagiotis; Mattsson, Mattias et al.

Part of Epigenetics, p. 449-455, 2016

• DOI for Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou, Nikos; Ntoufa, Stavroula; Chartomatsidou, Elisavet; Kotta, Konstantia et al.

Part of Oncotarget, p. 35946-35959, 2016

• DOI for The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Part of Haematologica, p. 959-967, 2016

• DOI for Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Bikos, Vasilis; Karypidou, Maria; Stalika, Evangelia; Baliakas, Panagiotis et al.

Part of Clinical Cancer Research, p. 2032-2040, 2016

• DOI for An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas, Panagiotis; Mattsson, Mattias; Stamatopoulos, Kostas; Rosenquist Brandell, Richard

Part of Journal of Internal Medicine, p. 347-357, 2016

• DOI for Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi, Sujata; Baliakas, Panagiotis; Cortese, Diego; Mattsson, Mattias et al.

Part of Haematologica, 2016

• DOI for UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Part of Blood, p. 1007-1016, 2016

• DOI for Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Reappraising prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis

2016

• Download full text (pdf) of Reappraising prognosis in chronic lymphocytic leukemia

ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

Bystry, Vojtech; Agathangelidis, Andreas; Bikos, Vasilis; Sutton, Lesley Ann et al.

Part of Bioinformatics, p. 3844-3846, 2015

• DOI for ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE

Agathangelidis, A.; Bystry, V.; Hadzidimitriou, A.; Sutton, L. A. et al.

Part of Haematologica, p. 47-48, 2015

ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE

Baliakas, Panagiotis; Puiggros, A.; Xochelli, Aliki; Sutton, L. -A et al.

Part of Haematologica, p. 224-224, 2015

Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Agathangelidis, Andreas; Rossi, Davide et al.

Part of Blood, p. 1043-1044, 2015

• DOI for Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Part of Blood, 2015

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann et al.

Part of Blood, p. 856-859, 2015

• DOI for Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Splenic marginal-zone lymphoma: ontogeny and genetics

Baliakas, Panagiotis; Strefford, Jonathan C.; Bikos, Vasilis; Parry, Marina et al.

Part of Leukemia and Lymphoma, p. 301-310, 2015

• DOI for Splenic marginal-zone lymphoma: ontogeny and genetics

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis; Hadzidimitriou, A; Sutton, Lesley Ann; Rossi, D et al.

Part of Leukemia, p. 329-336, 2015

• DOI for Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Psatha, Nikoleta; Sgouramali, Eleni; Gkountis, Antonios; Siametis, Athanasios et al.

Part of Human Gene Therapy Methods, p. 317-327, 2014

• DOI for Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Immunoglobulin Heavy Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL

Xochelli, A.; Agathangelidis, A.; Kavakiotis, I.; Minga, E. et al.

Part of Haematologica, p. 49-49, 2014

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann; Minga, Eva et al.

Part of LANCET HAEMATOLOGY, 2014

• DOI for Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Stereotyped B-cell receptors in chronic lymphocytic leukemia

Agathangelidis, Andreas; Vardi, Anna; Baliakas, Panagiotis; Stamatopoulos, Kostas

Part of Leukemia and Lymphoma, p. 2252-2261, 2014

• DOI for Stereotyped B-cell receptors in chronic lymphocytic leukemia

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Malcikova, Jitka; Stalika, Evangelia; Davis, Zadie; Plevova, Karla et al.

Part of British Journal of Haematology, p. 621-625, 2014

• DOI for The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Baliakas, Panagiotis; Iskas, Michalis; Gardiner, Anne; Davis, Zadie et al.

Part of American Journal of Hematology, p. 249-255, 2014

• DOI for Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Xochelli, Aliki; Kalpadakis, Christina; Gardiner, Anne; Baliakas, Panagiotis et al.

Part of Blood, p. 1199-1206, 2014

• DOI for Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Strefford, J. C.; Sutton, Lesley Ann; Baliakas, Panagiotis; Agathangelidis, A. et al.

Part of Leukemia, p. 2196-2199, 2013

• DOI for Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Soussi, Thierry; Kundu, Snehangshu; Gerbaud, Pauline; Pandzic, Tatjana et al.

Part of British Journal of Haematology, p. 1118-1121, 2025

• DOI for A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
• Download full text (pdf) of A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

Al-Djaber, Ahmed; Munters, Arielle; Cammenga, Jörg; Pandzic, Tatjana et al.

Part of eJHaem, 2025

• DOI for Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms
• Download full text (pdf) of Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Cozzi, Elisabetta; Neddermeyer, Anne; Zhong, Xiangfu; Gamboa-Cedeño, Angelica María et al.

Part of Cancer Gene Therapy, p. 1191-1205, 2025

• DOI for MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
• Download full text (pdf) of MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Hesselager, Caroline; Thörn, Ingrid; Marincevic, Millaray; Ladenvall, Claes et al.

Part of Blood neoplasia, 2025

• DOI for Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia
• Download full text (pdf) of Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

The TP53 tumor suppressor gene: From molecular biology to clinical investigations

Baliakas, Panagiotis; Soussi, Thierry

Part of Journal of Internal Medicine, p. 78-96, 2025

• DOI for The TP53 tumor suppressor gene: From molecular biology to clinical investigations
• Download full text (pdf) of The TP53 tumor suppressor gene: From molecular biology to clinical investigations

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Soussi, Thierry; Kundu, Snehangshu; Gerbaud, Pauline; Pandzic, Tatjana et al.

Part of British Journal of Haematology, p. 1118-1121, 2025

• DOI for A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
• Download full text (pdf) of A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

Al-Djaber, Ahmed; Munters, Arielle; Cammenga, Jörg; Pandzic, Tatjana et al.

Part of eJHaem, 2025

• DOI for Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms
• Download full text (pdf) of Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Cozzi, Elisabetta; Neddermeyer, Anne; Zhong, Xiangfu; Gamboa-Cedeño, Angelica María et al.

Part of Cancer Gene Therapy, p. 1191-1205, 2025

• DOI for MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
• Download full text (pdf) of MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Hesselager, Caroline; Thörn, Ingrid; Marincevic, Millaray; Ladenvall, Claes et al.

Part of Blood neoplasia, 2025

• DOI for Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia
• Download full text (pdf) of Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker

Thorvaldsdottir, Birna; Mansouri, Larry; Sutton, Lesley-Ann; Nadeu, Ferran et al.

Part of Leukemia, p. 1650-1660, 2025

• DOI for ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker
• Download full text (pdf) of ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker

Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer

Kvist, Anders; Kämpe, Anders; Törngren, Therese; Tesi, Bianca et al.

Part of Breast Cancer Research, 2025

• DOI for Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer
• Download full text (pdf) of Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

Visentin, Andrea; Gaffo, Enrico; Furstenau, Moritz; Rogers, Kerry A. et al.

Part of Leukemia, 2025

• DOI for Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
• Download full text (pdf) of Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study

Roncaglia, Eleonora; Gaffo, Enrico; Calabretto, Giulia; Fuerstenau, Moritz et al.

Part of Journal of Hematology & Oncology, 2025

• DOI for Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
• Download full text (pdf) of Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Tesi, Bianca; Robelius, Anna; Baskin, Berivan; Lazarevic, Vladimir et al.

Part of Clinical Cancer Research, p. 3062-3071, 2025

• DOI for Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
• Download full text (pdf) of Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL

Pavlova, Sarka; Malcikova, Jitka; Radova, Lenka; Bonfiglio, Silvia et al.

Part of HemaSphere, 2025

• DOI for Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
• Download full text (pdf) of Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Ernst, Martijn P. T.; Versluis, Jurjen; Valk, Peter J. M.; Bierings, Marc et al.

Part of HemaSphere, 2025

• DOI for Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
• Download full text (pdf) of Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Nyquist, Otto Emil; Dalgaard, Jakob; Spetalen, Signe; Torkildsen, Synne et al.

Part of British Journal of Haematology, p. 724-729, 2024

• DOI for Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Orsmark‐Pietras, Christina; Lyander, Anna; Ladenvall, Claes; Hallström, Björn et al.

Part of Genes, Chromosomes and Cancer, 2024

• DOI for Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel
• Download full text (pdf) of Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Part of Scientific Reports, 2024

• DOI for Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Download full text (pdf) of Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

Baliakas, Panagiotis; Munters, Arielle R; Kämpe, Anders; Tesi, Bianca et al.

Part of Journal of Medical Genetics, p. 150-154, 2024

• DOI for Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer
• Download full text (pdf) of Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

Baliakas, Panagiotis; Tesi, Bianca; Cammenga, Jörg; Stray-Pedersen, Asbjørg et al.

Part of HemaSphere, 2024

• DOI for How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
• Download full text (pdf) of How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

Visentin, Andrea; Chatzikonstantinou, Thomas; Scarfo, Lydia; Kapetanakis, Anargyros et al.

Part of American Journal of Hematology, p. 1856-1868, 2023

• DOI for The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
• Download full text (pdf) of The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity

Maliński, Bartosz; Vertemara, Jacopo; Faustini, Elena; Ladenvall, Claes et al.

Part of Human Molecular Genetics, p. 2901-2912, 2023

• DOI for Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity
• Download full text (pdf) of Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity

The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression

Cabrerizo Granados, David; Barbosa, Indira; Baliakas, Panagiotis; Hellström‐Lindberg, Eva et al.

Part of Genes, Chromosomes and Cancer, p. 672-677, 2023

• DOI for The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression
• Download full text (pdf) of The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression

T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations

Vlachonikola, Elisavet; Pechlivanis, Nikolaos; Karakatsoulis, Georgios; Sofou, Electra et al.

Part of Frontiers in Oncology, 2023

• DOI for T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations
• Download full text (pdf) of T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Part of Clinical Cancer Research, p. 2826-2834, 2023

• DOI for Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Mansouri, Larry; Thorvaldsdottir, Birna; Sutton, Lesley-Ann; Karakatsoulis, Georgios et al.

Part of Leukemia, p. 339-347, 2023

• DOI for Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
• Download full text (pdf) of Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella et al.

Part of Blood Advances, p. 2794-2806, 2023

• DOI for BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
• Download full text (pdf) of BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Tislevoll, Benedicte Sjo; Hellesoy, Monica; Fagerholt, Oda Helen Eck; Gullaksen, Stein-Erik et al.

Part of Nature Communications, 2023

• DOI for Early response evaluation by single cell signaling profiling in acute myeloid leukemia
• Download full text (pdf) of Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Ljungström, Viktor; Mattisson, Jonas; Halvardson, Jonatan; Pandzic, Tatjana et al.

Part of Leukemia, p. 889-891, 2022

• DOI for Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
• Download full text (pdf) of Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Baliakas, Panagiotis; Espinet, Blanca; Mellink, Clemens; Jarosova, Marie et al.

Part of HemaSphere, 2022

• DOI for Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
• Download full text (pdf) of Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Voso, Maria-Teresa; Pandzic, Tatjana; Falconi, Giulia; Dencic-Fekete, Marija et al.

Part of British Journal of Haematology, p. 103-113, 2022

• DOI for Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Engvall, Marie; Karlsson, Ylva; Kuchinskaya, Ekaterina; Jörnegren, Åsa et al.

Part of Leukemia and Lymphoma, p. 2311-2320, 2022

• DOI for Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
• Download full text (pdf) of Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Pandzic, Tatjana; Ladenvall, Claes; Engvall, Marie; Mattsson, Mattias et al.

Part of HemaSphere, 2022

• DOI for Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
• Download full text (pdf) of Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M.; Kyriakou, Charalampia et al.

Part of British Journal of Haematology, p. 431-441, 2022

• DOI for International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome

Baliakas, Panagiotis; Forsberg, Lars A.

Part of Haematologica, p. 329-331, 2021

• DOI for Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
• Download full text (pdf) of Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome

Prognostic and Predictive Implications of Cytogenetics and Genomics

Ljungström, Viktor; Baliakas, Panagiotis

Part of Hematology/Oncology Clinics of North America, p. 703-713, 2021

• DOI for Prognostic and Predictive Implications of Cytogenetics and Genomics
• Download full text (pdf) of Prognostic and Predictive Implications of Cytogenetics and Genomics

Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study

Leeksma, Alexander C.; Baliakas, Panagiotis; Moysiadis, Theodoros; Puiggros, Anna et al.

Part of Haematologica, p. 87-97, 2021

• DOI for Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
• Download full text (pdf) of Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study

Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169

Gemenetzi, Katerina; Psomopoulos, Fotis; Carriles, Alejandra A.; Gounari, Maria et al.

Part of Blood, p. 1895-1904, 2021

• DOI for Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Agathangelidis, Andreas; Chatzidimitriou, Anastasia; Gemenetzi, Katerina; Giudicelli, Veronique et al.

Part of Blood, p. 1365-1376, 2021

• DOI for Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Chatzikonstantinou, Thomas; Kapetanakis, Anargyros; Scarfò, Lydia; Karakatsoulis, Georgios et al.

Part of Leukemia, p. 3444-3454, 2021

• DOI for COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
• Download full text (pdf) of COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Part of American Journal of Hematology, 2020

• DOI for Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Download full text (pdf) of Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Baliakas, Panagiotis; Moysiadis, Theodoros; Hadzidimitriou, Anastasia; Xochelli, Aliki et al.

Part of Haematologica, p. 360-369, 2019

• DOI for Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
• Download full text (pdf) of Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; Stray-Pedersen, Asbjörg et al.

Part of HemaSphere, 2019

• DOI for Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
• Download full text (pdf) of Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Luo, Xi; Feurstein, Simone; Mohan, Shruthi; Porter, Christopher C. et al.

Part of Blood Advances, p. 2962-2979, 2019

• DOI for ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Moysiadis, Theodoros; Baliakas, Panagiotis; Rossi, Davide; Catherwood, Mark et al.

Part of Leukemia, p. 1801-1805, 2019

• DOI for Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Baliakas, Panagiotis; Jeromin, Sabine; Iskas, Michalis; Puiggros, Anna et al.

Part of Blood, p. 1205-1216, 2019

• DOI for Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

Norberg, Anna; Rosen, Anna; Raaschou-Jensen, Klas; Kjeldsen, Lars et al.

Part of European Journal of Human Genetics, p. 858-867, 2018

• DOI for Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, Anastasia; Minga, Eva et al.

Part of Haematologica, 2018

• DOI for No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Refractory chronic "ITP": When platelet size matters

Baliakas, Panagiotis; Kättström, Magdalena; Rossing, Maria; Amini, Rose-Marie

Part of Clinical Case Reports, p. 1779-1780, 2018

• DOI for Refractory chronic "ITP": When platelet size matters
• Download full text (pdf) of Refractory chronic "ITP": When platelet size matters

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

Xochelli, Aliki; Baliakas, Panagiotis; Kavakiotis, Ioannis; Agathangelidis, Andreas et al.

Part of Clinical Cancer Research, p. 5292-5301, 2017

• DOI for Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

CYTOGENETIC COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: DEFINITIONS, ASSOCIATIONS WITH OTHER BIOMARKERS AND CLINICAL IMPACT; A RETROSPECTIVE STUDY ON BEHALF OF ERIC

Baliakas, Panagiotis; Jeromin, S.; Iskas, M.; Puiggros, A. et al.

Part of Haematologica, p. 170-170, 2017

Is FCR the treatment of choice for IGHV mutated CLL without poor FISH cytogenetics?

Baliakas, Panagiotis; Moreno, Carol; Cuellar, Carolina; Scarfo, Lydia et al.

Part of Leukemia and Lymphoma, p. 170-171, 2017

• DOI for Is FCR the treatment of choice for IGHV mutated CLL without poor FISH cytogenetics?

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations with other bio-markers and clinical impact

Baliakas, Panagiotis; Jeronim, Sabine; Iskas, Michalis; Puiggros, Anna et al.

Part of Leukemia and Lymphoma, p. 65-66, 2017

• DOI for Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations with other bio-markers and clinical impact

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

Rosenquist, Richard; Ghia, P.; Hadzidimitriou, A.; Sutton, Lesley Ann et al.

Part of Leukemia, p. 1477-1481, 2017

• DOI for Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
• Download full text (pdf) of Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification

Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas et al.

Part of Haematologica, p. 968-971, 2017

• DOI for Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

Young, Emma; Noerenberg, Daniel; Mansouri, Larry; Ljungström, Viktor et al.

Part of Leukemia, p. 1547-1554, 2017

• DOI for EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors

Gemenetzi, Katerina; Galigalidou, Chrysi; Vlachonikola, Elisavet; Stalika, Evangelia et al.

Part of Leukemia and Lymphoma, p. 726-728, 2017

• DOI for Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Bhoi, Sujata; Ljungström, Viktor; Baliakas, Panagiotis; Mattsson, Mattias et al.

Part of Epigenetics, p. 449-455, 2016

• DOI for Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou, Nikos; Ntoufa, Stavroula; Chartomatsidou, Elisavet; Kotta, Konstantia et al.

Part of Oncotarget, p. 35946-35959, 2016

• DOI for The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Blanco, Gonzalo; Puiggros, Anna; Baliakas, Panagiotis; Athanasiadou, Anastasia et al.

Part of Oncotarget, p. 80916-80924, 2016

• DOI for Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
• Download full text (pdf) of Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Part of Haematologica, p. 959-967, 2016

• DOI for Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

No Improvement In Long-Term Overall Survival After The Introduction Of Chemo(Immuno)Therapy For Chronic Lymphocytic Leukemia Patients Belonging To Stereotyped Subset #2

Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, A.; Minga, E. et al.

Part of Haematologica, p. 231-231, 2016

Hypogammaglobulinemia In Chronic Lymphocytic Leukemia: Clinicobiological Associations

Baliakas, Panagiotis; Xochelli, Aliki; Minga, E.; Karavalakis, G. et al.

Part of Haematologica, p. 438-438, 2016

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

Baliakas, Panagiotis; Puiggros, Anna; Xochelli, Aliki; Sutton, Lesley-Ann et al.

Part of Haematologica, p. 299-302, 2016

• DOI for Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Bikos, Vasilis; Karypidou, Maria; Stalika, Evangelia; Baliakas, Panagiotis et al.

Part of Clinical Cancer Research, p. 2032-2040, 2016

• DOI for An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi, Sujata; Baliakas, Panagiotis; Cortese, Diego; Mattsson, Mattias et al.

Part of Haematologica, 2016

• DOI for UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Part of Blood, p. 1007-1016, 2016

• DOI for Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Gains of 8q and losses of 8p is associated with the presence of complex karyotype improving prognosis in patients with lymphatic leukemia chronic and alterations of tp53

Gonzalo, Blanco; Anna, Puiggros; Baliakas, Panagiotis; Anastasia, Athanasiadou et al.

Part of Haematologica, p. 196-197, 2016

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Navrkalova, Veronika; Young, Emma; Baliakas, Panagiotis; Radova, Lenka et al.

Part of Haematologica, 2016

• DOI for ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Chromosome 8 Abnormalities Are Associated With An Even Worse Outcome And Karyotype Complexity In Patients With Chronic Lymphocytic Leukemia And Tp53 Aberrations

Blanco, G.; Puiggros, A.; Baliakas, Panagiotis; Athanasiadou, A. et al.

Part of Haematologica, p. 229-230, 2016

Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

Xochelli, Aliki; Agathangelidis, Andreas; Kavakiotis, Ioannis; Minga, Evangelia et al.

Part of Immunogenetics, p. 61-66, 2015

• DOI for Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Xochelli, Aliki; Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia et al.

Part of Blood, 2015

ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

Bystry, Vojtech; Agathangelidis, Andreas; Bikos, Vasilis; Sutton, Lesley Ann et al.

Part of Bioinformatics, p. 3844-3846, 2015

• DOI for ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

Noerenberg, Daniel; Young, Emma; Ljungström, Viktor; Mansouri, Larry et al.

Part of Blood, 2015

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Part of Blood, 2015

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Navrkalova, Veronika; Young, Emma; Baliakas, Panagiotis; Radova, Lenka et al.

Part of Blood, 2015

HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE

Agathangelidis, A.; Bystry, V.; Hadzidimitriou, A.; Sutton, L. A. et al.

Part of Haematologica, p. 47-48, 2015

REFINING PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH SOMATICALLY HYPERMUTATED B-CELL RECEPTORS: A NOVEL PROGNOSTIC INDEX ON BEHALF OF THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC)

Baliakas, Panagiotis; Hadzidimitriou, A.; Mattsson, Mattias; Xochelli, Aliki et al.

Part of Haematologica, p. 52-52, 2015

ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE

Baliakas, Panagiotis; Puiggros, A.; Xochelli, Aliki; Sutton, L. -A et al.

Part of Haematologica, p. 224-224, 2015

Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Agathangelidis, Andreas; Rossi, Davide et al.

Part of Blood, p. 1043-1044, 2015

• DOI for Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Part of Blood, 2015

EGR2 mutations in chronic lymphocytic leukemiam - a new bad player?

Young, Emma; Norenberg, Daniel; Ljungstrom, Viktor; Mansouri, Larry et al.

Part of Leukemia and Lymphoma, p. 83-85, 2015

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann et al.

Part of Blood, p. 856-859, 2015

• DOI for Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis; Hadzidimitriou, A; Sutton, Lesley Ann; Rossi, D et al.

Part of Leukemia, p. 329-336, 2015

• DOI for Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Psatha, Nikoleta; Sgouramali, Eleni; Gkountis, Antonios; Siametis, Athanasios et al.

Part of Human Gene Therapy Methods, p. 317-327, 2014

• DOI for Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Trans location t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin

Xochelli, Aliki; Baliakas, Panagiotis; Moore, Sarah; Sole, Francesc et al.

Part of Cancer Genetics, p. 281-283, 2014

• DOI for Trans location t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin

Not All IGHV3-21 CLL Are Equal: Subset #2 Displays a Distinctive Clinicobiological Profile with Remarkable Similarities to Subset #169, its Close Immunogenetic Relative

Baliakas, Panagiotis; Hadzidimitriou, A.; Sutton, L. A.; Minga, E. et al.

Part of Haematologica, p. 48-49, 2014

Immunoglobulin Heavy Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL

Xochelli, A.; Agathangelidis, A.; Kavakiotis, I.; Minga, E. et al.

Part of Haematologica, p. 49-49, 2014

Cytogenetic Evolution Patterns in Chronic Lymphocytic Leukemia

Iskas, M.; Papaioannou, G.; Baliakas, Panagiotis; Gaitatzi, M. et al.

Part of Haematologica, p. 314-314, 2014

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann; Minga, Eva et al.

Part of LANCET HAEMATOLOGY, 2014

• DOI for Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Subset-Specific Spectra of Recurrent Gene Mutations in Chronic Lymphocytic Leukemia with Stereotyped B-Cell Receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Part of Blood, 2014

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Malcikova, Jitka; Stalika, Evangelia; Davis, Zadie; Plevova, Karla et al.

Part of British Journal of Haematology, p. 621-625, 2014

• DOI for The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Baliakas, Panagiotis; Iskas, Michalis; Gardiner, Anne; Davis, Zadie et al.

Part of American Journal of Hematology, p. 249-255, 2014

• DOI for Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Xochelli, Aliki; Kalpadakis, Christina; Gardiner, Anne; Baliakas, Panagiotis et al.

Part of Blood, p. 1199-1206, 2014

• DOI for Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Strefford, J. C.; Sutton, Lesley Ann; Baliakas, Panagiotis; Agathangelidis, A. et al.

Part of Leukemia, p. 2196-2199, 2013

• DOI for Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Clonal evolution patterns in high-risk chronic lymphocytic leukemia treated with ibrutinib

Mattsson, Mattias; Ljungström, Viktor; Djureinovic, Tatjana; Mansouri, Larry et al.

The TP53 tumor suppressor gene: From molecular biology to clinical investigations

Baliakas, Panagiotis; Soussi, Thierry

Part of Journal of Internal Medicine, p. 78-96, 2025

• DOI for The TP53 tumor suppressor gene: From molecular biology to clinical investigations
• Download full text (pdf) of The TP53 tumor suppressor gene: From molecular biology to clinical investigations

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Malcikova, Jitka; Pavlova, Sarka; Baliakas, Panagiotis; Chatzikonstantinou, Thomas et al.

Part of Leukemia, p. 1455-1468, 2024

• DOI for ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
• Download full text (pdf) of ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

Soussi, Thierry; Baliakas, Panagiotis

Part of Frontiers in Oncology, 2022

• DOI for Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
• Download full text (pdf) of Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Chatzikonstantinou, Thomas; Demosthenous, Christos; Baliakas, Panagiotis

Part of Frontiers in Oncology, 2021

• DOI for Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype
• Download full text (pdf) of Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas, Panagiotis; Mattsson, Mattias; Stamatopoulos, Kostas; Rosenquist Brandell, Richard

Part of Journal of Internal Medicine, p. 347-357, 2016

• DOI for Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Splenic marginal-zone lymphoma: ontogeny and genetics

Baliakas, Panagiotis; Strefford, Jonathan C.; Bikos, Vasilis; Parry, Marina et al.

Part of Leukemia and Lymphoma, p. 301-310, 2015

• DOI for Splenic marginal-zone lymphoma: ontogeny and genetics

Stereotyped B-cell receptors in chronic lymphocytic leukemia

Agathangelidis, Andreas; Vardi, Anna; Baliakas, Panagiotis; Stamatopoulos, Kostas

Part of Leukemia and Lymphoma, p. 2252-2261, 2014

• DOI for Stereotyped B-cell receptors in chronic lymphocytic leukemia

Reappraising prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis

2016

• Download full text (pdf) of Reappraising prognosis in chronic lymphocytic leukemia

Accumulation of High-Risk Genetic Features after Chemoimmunotherapy: A Longitudinal Study in Mantle Cell Lymphoma

Nikkarinen, Anna; Almlöf, Jonas; Österroos, Albin; Ladenvall, Claes et al.

Impact of Clonal Hematopoiesis on Hematological Treatment Toxicity in Mantle Cell Lymphoma Patients

Nikkarinen, Anna; Selvin, Tove; Almlöf, Jonas; Österroos, Albin et al.